LATEST

• BUSINESS Ferring’s Adstiladrin, Boehringer’s Jascayd Hit Market; Haizexin Due July 28
  July 16, 2026

• BUSINESS Nipro Pharma Recalls Topical Drugs over Long-Running Manufacturing Deviations
  July 16, 2026

• BUSINESS JCR to File DMD Drug Givinostat in Japan by End-2026
  July 16, 2026

• BUSINESS Daiichi Sankyo Healthcare to Take Over Claritin EX Sales in Japan
  July 16, 2026

• BUSINESS Maruishi Set to Secure Japan Rights to Kringle’s Vocal Fold Scar Drug
  July 16, 2026

• BUSINESS DNP to Acquire Kyowa Pharma Chemical in CDMO Expansion
  July 16, 2026

• BUSINESS LinDo Gets Japan Rights to Proveca’s Pediatric Drooling Drug
  July 16, 2026

• BUSINESS Over 80% of Early AD Patients Stable or Improved on Leqembi: Study
  July 16, 2026

• ORGANIZATION WHO Opens Tokyo Hub to Help Health Systems in Developing Nations
  July 16, 2026

• REGULATORY Japan to Consider Support for Domestic Immunoglobulin Production: Minister
  July 16, 2026

• REGULATORY Govt Set to Amend Honebuto Draft over Inflation, MFN Language
  July 16, 2026

• REGULATORY HHS Report Puts Japan’s Drug Innovation Financing Well Behind US
  July 15, 2026

• ORGANIZATION FIRM Unveils Vision 2030 to Bolster Japan’s Regenerative Medicine Industry
  July 15, 2026

• BUSINESS FRONTEO, Daiichi Sankyo Build AI Model to Analyze Toxicity Reports
  July 15, 2026

• REGULATORY MHLW Orders Label Revisions for PPIs, Checkpoint Inhibitors
  July 15, 2026

• BUSINESS Cell Resources Launches Umbilical Cord- and Amnion-Derived MSCs
  July 15, 2026

• BUSINESS iPark Eyes Shared AI Platform to Keep Japan in Global Drug Discovery Race
  July 14, 2026

• REGULATORY Japan Panel to Review Brinsupri, Hyrnuo, Inlexzo, GSK’s Hep B Med on July 27
  July 14, 2026

• REGULATORY CEA Review Group Debates Comparator Technologies, ICER Uncertainty
  July 14, 2026

• BUSINESS FDA Greenlights Leqembi Iqlik for Alzheimer’s Initiation Therapy
  July 14, 2026

ページ

• « 先頭
• ‹ Prev
• …
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• …
• Next ›
• 最終 »